Your browser doesn't support javascript.
loading
Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant.
Waerlop, Gwenn; Janssens, Yorick; Jacobs, Bart; Jarczowski, Franziska; Diessner, André; Leroux-Roels, Geert; Klimyuk, Victor; Leroux-Roels, Isabel; Thieme, Frank.
Afiliación
  • Waerlop G; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Janssens Y; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Jacobs B; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Jarczowski F; Icon Genetics GmbH, a Denka Company, Halle, Germany.
  • Diessner A; Icon Genetics GmbH, a Denka Company, Halle, Germany.
  • Leroux-Roels G; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Klimyuk V; Icon Genetics GmbH, a Denka Company, Halle, Germany.
  • Leroux-Roels I; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Thieme F; Icon Genetics GmbH, a Denka Company, Halle, Germany.
Front Immunol ; 14: 1188431, 2023.
Article en En | MEDLINE | ID: mdl-37435073

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adyuvantes Inmunológicos / Norovirus Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adyuvantes Inmunológicos / Norovirus Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Bélgica